"Study Confirms Popular Weight Loss Drugs Ozempic, Wegovy Do Not Raise Suicide Risk"

A study published in Nature Medicine has found no evidence that the weight loss and diabetes drugs Wegovy and Ozempic, which contain the active ingredient semaglutide, increase the risk of suicidal thoughts. The research, which analyzed health records of millions of U.S. patients, actually showed a lower risk of suicidal ideation among those taking semaglutide compared to other medications for obesity and type 2 diabetes. This comes as a positive sign amidst ongoing investigations by health agencies in Europe and the U.S. into the potential side effects of these popular drugs. Further research is needed to explore any causal relationships and long-term effects, as well as the potential of semaglutide in curbing addiction and compulsive behaviors.